Bactana has signed a distribution agreement with France-based ArcaNatura SAS to launch Bactana’s first commercial product, Pawsni™ Glucose Control.
FPZ-100, Bactana’s patent pending active ingredient in Pawsni Glucose Control, has been shown to significantly reduce diabetic and prediabetic blood markers in multiple placebo-controlled mouse trials without causing undesirable hypoglycemic side effects.
Bactana is developing a complete line of Pawsni branded products that all utilize the scientifically tested benefits of FPZ-100 to improve the lives of companion animals.
ArcaNatura is one of the largest providers of pet supplements to French veterinary clinics and is the exclusive distributor for several of the country’s best selling brands, including Dasuquin®, Cosequin®, and Denamarin®.